Item 5.07. Submission of Matters to a Vote of Security Holders.

Cardinal Health, Inc. (the "Company") held its 2022 Annual Meeting of Shareholders (the "Annual Meeting") on November 9, 2022. See the Company's definitive proxy statement for the Annual Meeting filed with the Securities and Exchange Commission on September 28, 2022 (the "Proxy Statement") for more information on the three proposals included in the Proxy Statement for the Annual Meeting.

Proposal 1. The shareholders elected the 13 nominees listed below to the Company's Board of Directors, each to serve until the 2023 Annual Meeting of Shareholders and until their successor is duly elected and qualified or until their earlier resignation, removal from office or death, and voted as follows:



  Nominee                                  For      Against   Abstained     Broker Non-Votes
  Steven K. Barg                   202,651,413      846,605     698,356           25,132,179
  Michelle M. Brennan              202,664,643      849,411     682,320           25,132,179
  Sujatha Chandrasekaran           202,665,819      837,984     692,571           25,132,179
  Carrie S. Cox                    175,425,242   28,029,748     741,384           25,132,179
  Bruce L. Downey                  191,511,168   11,918,084     767,122           25,132,179
  Sheri H. Edison                  202,223,804    1,285,528     687,042           25,132,179
  David C. Evans                   200,751,856    2,747,834     696,684           25,132,179
  Patricia A. Hemingway Hall       198,435,528    5,013,088     747,758           25,132,179
  Jason M. Hollar                  202,218,082    1,285,541     692,751           25,132,179
  Akhil Johri                      202,136,509    1,363,909     695,956           25,132,179
  Gregory B. Kenny                 189,660,047   13,842,463     693,864           25,132,179
  Nancy Killefer                   198,492,574    5,020,073     683,727           25,132,179
  Christine A. Mundkur             202,672,777      838,823     684,774           25,132,179

Proposal 2. The shareholders ratified the appointment of Ernst & Young LLP as the Company's independent auditor for the fiscal year ending June 30, 2023, and voted as follows:


     For         Against    Abstained    Broker Non-Votes
 220,482,418    8,302,561    543,574            -

Proposal 3. The shareholders approved, on a non-binding advisory basis, the compensation of the Company's named executive officers, and voted as follows:


     For         Against     Abstained    Broker Non-Votes
 184,983,772    18,266,030    946,572        25,132,179


                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses